The purpose of this study is to compare visual performance and quality of life (QOL) following bilateral implantation of a novel non-diffractive extended depth-of-focus (EDOF) intraocular lens (IOL) (AcrySof® IQ Vivity, Alcon, TX, USA) and a trifocal IOL (Acrysof® IQ PanOptix, Alcon, Fort Worth, TX) in a prospective comparative interventional case series.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Postoperative visual acuity with or without spectacle correction at near, far and intermediate distances
Timeframe: postoperative third month
Defocus-curves
Timeframe: postoperative third month
Contrast sensitivity
Timeframe: postoperative third month
Reading speed
Timeframe: postoperative third month
Quality of vision / dysphotopsia
Timeframe: postoperative third month
Vision-related quality of life (QOL)
Timeframe: postoperative third month